# C4 Therapeutics, Inc.: Form 8-K, filed Nov 30, 2021

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: 8-K
- Filed: 2021-11-30
- Accepted by EDGAR: Nov 30, 2021, 16:18 ET
- Period: 2021-11-24
- Accession: 0001564590-21-058797
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000156459021058797/cccc-8k_20211124.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000156459021058797/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000156459021058797/cccc-8k_20211124.htm

Filed Nov 30, 2021.
Source: SEC EDGAR, the filing index for accession 0001564590-21-058797. Last ingested by Listed: Nov 5, 2026, 12:02 ET. No prices; not investment advice.